| Ytd | 6.60% | |
| 1y | -26.23% |
| Open | 4.01 | Prev Close | 3.95 | Low | 3.89 | High | 4.43 | Mkt Cap | 2.34B |
| Vol | 35.50M | Avg Vol | 20.70M | EPS | -1.10 | P/E | N/A | Forward P/E | -4.83 |
| Beta | 1.03 | Short Ratio | 11.32 | Inst. Own | 71.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 3.53 | 200-d Avg | 3.57 | 1yr Est | 7.22 |
RXRX News
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX - Get Free Report) fell 4.3% during trading
Oramed Pharmaceuticals (NASDAQ: ORMP - Get Free Report) and Recursion Pharmaceuticals (NASDAQ: RXRX
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.63, representing a -3.14%
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia,
Ten stocks have over 34% of their float short, with ONDS and BROS on the list led by VG.
Tempus AI, Inc. (NASDAQ:TEM) today announced an extension of its data license agreement with Recursi
Recursion Pharmaceuticals (NASDAQ:RXRX) reported second-quarter financial results on Wednesday. The
Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on posi
Cramer likes Vistra and Constellation, but not NextEra. Recursion and Fastly reported weak earnings,
Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.25) per share which missed
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de
ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, R
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshapi
Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 milli
Recursion (NASDAQ:RXRX) a leading clinical stage TechBio company decoding biology to radically impro
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective an
Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session a
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarter
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pr
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Friday. Here are some big
Friday's session saw 104 companies set new 52-week lows.
On Thursday, 185 companies achieved new lows for the year.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.